The Future of Blood Testing Is the Immunome - Sorbonne Université Access content directly
Journal Articles Frontiers in Immunology Year : 2021

The Future of Blood Testing Is the Immunome


It is increasingly clear that an extraordinarily diverse range of clinically important conditions—including infections, vaccinations, autoimmune diseases, transplants, transfusion reactions, aging, and cancers—leave telltale signatures in the millions of V(D)J-rearranged antibody and T cell receptor [TR per the Human Genome Organization (HUGO) nomenclature but more commonly known as TCR] genes collectively expressed by a person’s B cells (antibodies) and T cells. We refer to these as the immunome . Because of its diversity and complexity, the immunome provides singular opportunities for advancing personalized medicine by serving as the substrate for a highly multiplexed, near-universal blood test. Here we discuss some of these opportunities, the current state of immunome-based diagnostics, and highlight some of the challenges involved. We conclude with a call to clinicians, researchers, and others to join efforts with the Adaptive Immune Receptor Repertoire Community (AIRR-C) to realize the diagnostic potential of the immunome.
Fichier principal
Vignette du fichier
Arnaout et al. - 2021 - The Future of Blood Testing Is the Immunome.pdf (14.79 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03838033 , version 1 (08-11-2022)



Ramy Arnaout, Eline Prak, Nicholas Schwab, Florian Rubelt, Encarnita Mariotti-Ferrandiz. The Future of Blood Testing Is the Immunome. Frontiers in Immunology, 2021, 12, pp.626793. ⟨10.3389/fimmu.2021.626793⟩. ⟨hal-03838033⟩
20 View
16 Download



Gmail Mastodon Facebook X LinkedIn More